281 related articles for article (PubMed ID: 18160670)
1. Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.
Tiedt R; Hao-Shen H; Sobas MA; Looser R; Dirnhofer S; Schwaller J; Skoda RC
Blood; 2008 Apr; 111(8):3931-40. PubMed ID: 18160670
[TBL] [Abstract][Full Text] [Related]
2. Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth.
Li Z; Xu M; Xing S; Ho WT; Ishii T; Li Q; Fu X; Zhao ZJ
J Biol Chem; 2007 Feb; 282(6):3428-32. PubMed ID: 17178722
[TBL] [Abstract][Full Text] [Related]
3. Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.
Stetka J; Usart M; Kubovcakova L; Rai S; Rao TN; Sutter J; Hao-Shen H; Dirnhofer S; Geier F; Bader MS; Passweg JR; Manolova V; Dürrenberger F; Ahmed N; Schroeder T; Ganz T; Nemeth E; Silvestri L; Nai A; Camaschella C; Skoda RC
Blood; 2023 Apr; 141(17):2127-2140. PubMed ID: 36758212
[TBL] [Abstract][Full Text] [Related]
4. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
Scott LM; Tong W; Levine RL; Scott MA; Beer PA; Stratton MR; Futreal PA; Erber WN; McMullin MF; Harrison CN; Warren AJ; Gilliland DG; Lodish HF; Green AR
N Engl J Med; 2007 Feb; 356(5):459-68. PubMed ID: 17267906
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow niche.
Flosdorf N; Böhnke J; de Toledo MAS; Lutterbach N; Lerma VG; Graßhoff M; Olschok K; Gupta S; Tharmapalan V; Schmitz S; Götz K; Schüler HM; Maurer A; Sontag S; Küstermann C; Seré K; Wagner W; Costa IG; Brümmendorf TH; Koschmieder S; Chatain N; Castilho M; Schneider RK; Zenke M
Stem Cell Reports; 2024 Feb; 19(2):224-238. PubMed ID: 38278152
[TBL] [Abstract][Full Text] [Related]
6. SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.
Yang Y; Abbas S; Sayem MA; Dutta A; Mohi G
Blood Cancer J; 2023 Nov; 13(1):171. PubMed ID: 38012156
[TBL] [Abstract][Full Text] [Related]
7. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency.
Aladağ E; Aksu S; Demiroğlu H; Sayınalp N; Göker H; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
Turk J Med Sci; 2019 Oct; 49(5):1560-1563. PubMed ID: 31652037
[TBL] [Abstract][Full Text] [Related]
8. Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging.
Santisakultarm TP; Paduano CQ; Stokol T; Southard TL; Nishimura N; Skoda RC; Olbricht WL; Schafer AI; Silver RT; Schaffer CB
J Thromb Haemost; 2014 Dec; 12(12):2120-30. PubMed ID: 25263265
[TBL] [Abstract][Full Text] [Related]
9. Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice.
Fisher DAC; Laranjeira ABA; Kong T; Snyder SC; Shim K; Fulbright MC; Oh ST
Exp Hematol; 2023 Dec; 128():48-66. PubMed ID: 37611729
[TBL] [Abstract][Full Text] [Related]
10. Polycythemia is associated with bone loss and reduced osteoblast activity in mice.
Oikonomidou PR; Casu C; Yang Z; Crielaard B; Shim JH; Rivella S; Vogiatzi MG
Osteoporos Int; 2016 Apr; 27(4):1559-1568. PubMed ID: 26650379
[TBL] [Abstract][Full Text] [Related]
11. Mapping genotypes to chromatin accessibility profiles in single cells.
Izzo F; Myers RM; Ganesan S; Mekerishvili L; Kottapalli S; Prieto T; Eton EO; Botella T; Dunbar AJ; Bowman RL; Sotelo J; Potenski C; Mimitou EP; Stahl M; El Ghaity-Beckley S; Arandela J; Raviram R; Choi DC; Hoffman R; Chaligné R; Abdel-Wahab O; Smibert P; Ghobrial IM; Scandura JM; Marcellino B; Levine RL; Landau DA
Nature; 2024 May; 629(8014):1149-1157. PubMed ID: 38720070
[TBL] [Abstract][Full Text] [Related]
12. Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
Kilani B; Gourdou-Latyszenok V; Guy A; Bats ML; Peghaire C; Parrens M; Renault MA; Duplàa C; Villeval JL; Rautou PE; Couffinhal T; James C
J Thromb Haemost; 2019 May; 17(5):827-840. PubMed ID: 30801958
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of the p19/CDK4/CDK6 axis in Jak2
Duparc H; Muller D; Gilles L; Chédeville AL; El Khoury M; Guignard R; Debili N; Wittner M; Kauskot A; Pasquier F; Antony-Debré I; Marty C; Vainchenker W; Plo I; Raslova H
Leukemia; 2024 Apr; 38(4):898-902. PubMed ID: 38378843
[No Abstract] [Full Text] [Related]
14. The clonal hematopoiesis mutation Jak2
Molinaro R; Sellar RS; Vromman A; Sausen G; Folco E; Sukhova GK; McConke ME; Corbo C; Ebert BL; Libby P
Int J Cardiol; 2024 May; 409():132184. PubMed ID: 38759798
[TBL] [Abstract][Full Text] [Related]
15. A New Murine Model of Clonal Hematopoiesis Investigates
Patel AP; Natarajan P
JACC Basic Transl Sci; 2019 Oct; 4(6):698-700. PubMed ID: 31713537
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic JAK2
Sano S; Walsh K
J Cardiovasc Aging; 2021; 1():. PubMed ID: 34396370
[No Abstract] [Full Text] [Related]
17. Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN.
Grisouard J; Shimizu T; Duek A; Kubovcakova L; Hao-Shen H; Dirnhofer S; Skoda RC
Blood; 2015 Mar; 125(13):2131-40. PubMed ID: 25595737
[TBL] [Abstract][Full Text] [Related]
18. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
Arranz L; Sánchez-Aguilera A; Martín-Pérez D; Isern J; Langa X; Tzankov A; Lundberg P; Muntión S; Tzeng YS; Lai DM; Schwaller J; Skoda RC; Méndez-Ferrer S
Nature; 2014 Aug; 512(7512):78-81. PubMed ID: 25043017
[TBL] [Abstract][Full Text] [Related]
19. Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNs.
Duek A; Lundberg P; Shimizu T; Grisouard J; Karow A; Kubovcakova L; Hao-Shen H; Dirnhofer S; Skoda RC
Blood; 2014 Jun; 123(25):3943-50. PubMed ID: 24820309
[TBL] [Abstract][Full Text] [Related]
20. Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F.
Lundberg P; Takizawa H; Kubovcakova L; Guo G; Hao-Shen H; Dirnhofer S; Orkin SH; Manz MG; Skoda RC
J Exp Med; 2014 Oct; 211(11):2213-30. PubMed ID: 25288396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
